Drug Type mRNA |
Synonyms- |
Target |
Mechanism TLR antagonists(Toll-like receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | 21 Nov 2022 | |
Anxiety Disorders | Preclinical | - | 19 Nov 2022 | |
Alzheimer Disease | Preclinical | - | 15 Oct 2016 |